For many investors, the experimental psychedelics industry may be too risky to invest in. Most companies in this sector are privately held, and psychedelic stocks are often volatile penny or OTC stocks.
Aside from being risky, these stocks can also be difficult to purchase. Most stocks will require you to have a brokerage account that offers access to OTC and international stocks, like Interactive Brokers or TradeStation.For investors willing to take the risk, the best psychedelic stocks depend on your portfolio and investment goals — while volatility can be ideal for day traders, long-term investors will want to look to stocks with steadier gains over time.
The top experimental drug stocks included on this page all trade on the S&P 500, have an analyst recommendation of "Buy" or better and are sorted by year-to-date performance.
Top pick for banking + investing in one app
Top pick for copy trading
Get 12 free shares
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020.
Compass Pathways Plc stock opened the day at $12.00 after a previous close of $12.00. The latest price was $11.84 (25-minute delay). Compass Pathways Plc is listed on the NASDAQ and employs 156 staff.
Mind Medicine (MindMed) Inc. , a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
Mind Medicine MindMed stock opened the day at $0.00 after a previous close of $0.00. The latest price was $0.00 (25-minute delay). Mind Medicine MindMed is listed on the OTCQB and employs 22 staff.
Mycotopia Therapies Inc. provides psychedelic therapies through technology-focused, data-driven, and medical-based solutions for people dealing with anxiety, depression, bipolar disorders, PTSD, ADHD, autism, and addictions. The company was incorporated in 2019 and is based in Aventura, Florida.
Mycotopia Therapies stock opened the day at $0.00 after a previous close of $0.00. The latest price was $0.00 (25-minute delay). Mycotopia Therapies is listed on the PINK and employs 1 staff.
Numinus Wellness Inc. provides solutions to develop and deliver psychedelic-assisted psychotherapy and transform the mental health landscape. The company operates in two divisions, Salvation Botanicals and Numinus Health.
Numinus Wellness stock opened the day at C$0.00 after a previous close of C$0.00. The latest price was C$0.00 (25-minute delay). Numinus Wellness is listed on the V and has a trailing 12-month revenue of around CAD$1.5 million. All prices are listed in Canadian Dollars.
Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate.
Mindset Pharma stock opened the day at C$0.00 after a previous close of C$0.00. The latest price was C$0.00 (25-minute delay). Mindset Pharma is listed on the CN and has a trailing 12-month revenue of around CADC$7.8 million. All prices are listed in Canadian Dollars.
Cybin Inc. , a biotechnology company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Cybin U. S.
Cybin Inc stock opened the day at $0.00 after a previous close of $0.00. The latest price was $0.00 (25-minute delay). Cybin Inc is listed on the OTCQB, has a trailing 12-month revenue of around USDC$864,000 and employs 38 staff.
Field Trip Health Ltd. engages in the development and delivery of psychedelic therapies. Its Research division is involved in the development of psychedelic molecules and conducting research on plant-based psychedelics.
Field Trip Health stock opened the day at C$0.00 after a previous close of C$0.00. The latest price was C$0.00 (25-minute delay). Field Trip Health is listed on the CN and has a trailing 12-month revenue of around CAD$435,460. All prices are listed in Canadian Dollars.
Check out Finder's picks for the best brokerage accounts
Compare top brokerage accounts and apps to help you maximize your investment.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Three ETFs built to smooth out the ride, including SPHD, which pairs low volatility with a high monthly dividend.
Four dividend ETFs for overall quality, growth, high yield and monthly income, plus an honest look at why “weekly dividend ETFs” aren’t what they sound like.
A daily list of the most actively traded US stocks by volume, including the most active under $5.
Seven bond ETFs covering core exposure, municipal income, safety, corporate credit, inflation protection and high yield, each checked against the issuer’s own fund page.
We compare 8 TradingView alternatives on cost, charting depth and real-time data, including several genuinely free options.
Connect an AI agent like Claude or ChatGPT to a ring-fenced Robinhood account and let it trade for you. Here’s how it works, what it can trade, and the risks before you switch it on.
Our top 10 beginner-friendly stocks and ETFs, and why we picked them — plus 7 more.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
We’ve rounded up stats on some of the most popular oil stocks, along with information on how they compare and how to invest.
Six stocks that cleared our October 2026 screen for quality, growth and balance-sheet strength.